Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cervical cancer
|
268 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Cervix carcinoma
|
283 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Malignant Testicular Germ Cell Tumor
|
62 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||
Prostate specific antigen measurement
|
95 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||
Squamous cell carcinoma of the head and neck
|
348 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of skin
|
38 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Skin carcinoma
|
24 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Carcinoma of bladder
|
309 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.710 | 0.667 | 3 | 2010 | 2014 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.710 | 0.667 | 3 | 2010 | 2014 | |||||
Squamous cell carcinoma
|
257 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||
Small cell carcinoma of lung
|
125 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.020 | 0.500 | 2 | 2013 | 2014 | |||||
Bladder Neoplasm
|
281 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1 | 2014 | 2014 | ||||||
Lymphoma, Non-Hodgkin
|
197 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Nicotine Dependence
|
178 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Squamous cell carcinoma of lung
|
283 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
melanoma
|
515 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.860 | 1.000 | 7 | 2010 | 2015 | |||||
Malignant neoplasm of pancreas
|
277 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.740 | 1.000 | 5 | 2010 | 2015 | |||||
Basal Cell Cancer
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Basal cell carcinoma
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Basal Cell Neoplasm
|
109 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 3 | 2009 | 2015 | |||||
Adenocarcinoma
|
168 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.040 | 1.000 | 4 | 2013 | 2016 | |||||
Nasopharyngeal carcinoma
|
320 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.720 | 1.000 | 3 | 2010 | 2016 | |||||
Esophageal carcinoma
|
272 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Nasopharyngeal Neoplasms
|
36 | 0.620 | 0.640 | 5 | 1321972 | intron variant | C/T | snv | 0.48 | 0.700 | 1.000 | 1 | 2016 | 2016 |